Skip to content

Comparison of Different Methods of Nasogastric Tube Insertion in Anesthetized and Intubated Patients

Comparison of Different Methods of Nasogastric Tube Insertion in Anesthetized and Intubated Patients: A Prospective Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02557204
Enrollment
200
Registered
2015-09-23
Start date
2015-09-30
Completion date
2015-11-30
Last updated
2015-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorder of Abdomen

Keywords

nasogastric tube insertion, Video laryngoscope, success rate

Brief summary

The primary aim of this study is to investigate the difference in the first attempt and overall success rate of different techniques for insertion of nasogastric tube. Secondary aim is to investigate the difference of the duration of insertion using the selected technique, complications during insertion such as kinking, knotting, mucosal bleeding

Detailed description

Two hundred adult patients, who received general anaesthesia for elective abdominal surgeries that required nasogastric tube insertion, will be randomized by means of a computer-generated randomization order into four groups: Conventional group (Group C), head in the lateral position group (Group L), endotracheal tube assisted group (group ET) and video laryngoscope group (group MG). Success rate of the selected technique (first attempt, second attempt and overall), duration of insertion for selected technique, complications such as kinking and mucosal bleeding will be noted.

Interventions

the nasogastric tube will be inserted gently through a selected nostril with the head being maintained in the neutral position.

PROCEDUREhead in the lateral position technique

the patient's head will be turned to the right lateral position. Nasogastric tube will be inserted through the right nostril without any maneuvers of the neck.

PROCEDUREendotracheal tube assisted technique

Nasogastric tube will be inserted the trimmed 7.5 mm internal diameter endotracheal tube what cut proximal end with sterile scissors and endotracheal tube will be advanced blindly into the oral cavity to a depth of approximately 18 cm without laryngoscope together the nasogastric tube.

Nasogastric tube was inserted transnasally and advanced into esophagus under direct vision.

Sponsors

Antalya Training and Research Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients who received general anaesthesia for elective abdominal surgeries that required nasogastric tube insertion.

Exclusion criteria

* Patients with a history of coagulopathy, * nasal stenosis, * upper respiratory tract diseases or anomalies, * esophageal varix, esophageal hiatus hernia, * base of skull fracture, * loose teeth, * Cormack and Lehane and/or Mallampati scores of 3 or 4, * patients younger than 18 years and older than 70 years

Design outcomes

Primary

MeasureTime frameDescription
difference in the first attempt and overall success rateparticipants will be followed to the starting from the NG tube insert through the nostril until the confirm to successful insertion into stomach.investigate the difference in the first attempt and overall success rate (with percentage) of different techniques for insertion of nasogastric tube.

Secondary

MeasureTime frameDescription
difference of the duration of insertion and complications during insertionparticipants will be followed for the duration of intraoperative period and postoperative 4 hours.investigate the difference of the duration of insertion (in seconds) using the selected technique and complications (with number and percentage) during insertion such as kinking, knotting, mucosal bleeding

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026